Clinical study on the efficacy of Teprenone for the cognitive impairment in patients with Alzheimer's disease.
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000016843
- Lead Sponsor
- anpuh Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Not provided
1) Patients with dementia except Alzheimer's disease 2) Patients with central nervous system infection 3) Normal pressure hydrocephalus merger patients 4) Patients that vitamin deficiency, electrolyte abnormality, a dysfunction thyroid are clear 5) Patients with schizophrenia 6) Patients with sensitivity to piperidine derivative containing donepezil or teprenone, Children, pregnant woman and lactating woman 7) Patients after the gallbladder extraction 8) Patients with visual disturbances, hearing impairment, and writing and literacy difficulties that affect the assessment of the neuropsychological test 9) Patients who received the drugs for Alzheimer's disease within 30 days before registration 10) Patients who received Teprenone 14 days before registration 11) Patients who are inappropriate to participate judge by attendant doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method